U.S. MARKETS FOR PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY AND CORONARY STENT PRODUCTS

224 Pages | 54 Exhibits | 2002 Analysis | Forecasts Through 2006

OVERVIEW:
Despite major technology-driven advances in the management of coronary artery disease, more than 450,000 people die from the condition in the United States each year. The morbidity and mortality associated with the disease continue to fuel the demand for products used to treat advanced cases that cannot be adequately managed via medical therapy. In the 21st century, percutaneous intervention is considered the coronary artery disease treatment of choice, with annual sales of percutaneous transluminal coronary angioplasty and coronary stenting products exceeding $2.4 billion.

This report from Medtech Insight includes analyses of technologies, products, current and forecast markets, competitors, and opportunities in the percutaneous transluminal coronary angioplasty and coronary stenting products market.

Major topics include: balloon & guiding catheters; coronary stent materials & designs; coronary stent restenosis treatment systems; coronary stenting applications & approaches; guidewires & sheath introducers; inflation & arterial access closure devices; managed care, third-party payers & reimbursement; transcatheter techniques; and vulnerable plaque detection & treatment.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Evolution of Coronary Artery Disease Management
ii. Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting Products Market
iii. Percutaneous Transluminal Coronary Angioplasty Balloon Catheters
iv. Coronary Guiding Catheters
v. Coronary Guidewires
vi. Introducer Sheaths
vii. Percutaneous Transluminal Coronary Angioplasty/Coronary Stenting Inflation Devices
viii. Arterial Access Closure Devices
ix. Coronary Stent Systems
x. Intravascular Brachytherapy Systems
xi. Report Methodology

Exhibit ES-1: Ischemic Heart Disease Diagnoses for Patients Discharged from Acute Care Hospitals, 1995-1999 
Exhibit ES-2: Percutaneous Transluminal Coronary Angioplasty and Coronary Stent Implantations, Historic and Forecast Procedure Volumes, 1993-2006 
Exhibit ES-3: Percutaneous Transluminal Coronary Angioplasty and Coronary Stent Products, Market Forecast, 2000-2006 
Exhibit ES-4: Percutaneous Transluminal Coronary Angioplasty Balloon Catheters, Market Forecast, 2000-2006 
Exhibit ES-5: Coronary Guiding Catheters, Market Forecast, 2000-2006 
Exhibit ES-6: Coronary Guidewires, Market Forecast, 2000-2006 
Exhibit ES-7: Introducer Sheaths, Market Forecast, 2000-2006 
Exhibit ES-8: Percutaneous Transluminal Coronary Angioplasty/Stenting Inflation Devices, Market Forecast, 2000-2006
Exhibit ES-9: Arterial Access Closure Devices, Market Forecast, 2000-2006 
Exhibit ES-10: Coronary Stent Systems, Market Forecast, 2000-2006 
Exhibit ES-11: Intravascular Brachytherapy Systems, Market Forecast, 2000-2006 
 
1. OVERVIEW OF CORONARY ARTERY DISEASE MANAGEMENT

1.1 Coronary Artery Disease
	1.1.1 Types
		1.1.1.1 Atherosclerosis
			1.1.1.1.1 Etiology and Symptomology
			1.1.1.1.2 Incidence and Prevalence
		1.1.1.2 Angina Pectoris
			1.1.1.2.1 Etiology and Symptomology
			1.1.1.2.2 Incidence and Prevalence
		1.1.1.3 Myocardial Infarction
			1.1.1.3.1 Etiology and Symptomology
			1.1.1.3.2 Incidence and Prevalence
	1.1.2 Disease Management
		1.1.2.1 Medical Management
			1.1.2.1.1 Lifestyle Changes
			1.1.2.1.2 Pharmaceuticals
		1.1.2.2 Surgical Intervention
			1.1.2.2.1 Coronary Artery Bypass Grafting
			1.1.2.2.2 Transmyocardial Revascularization
		1.1.2.3 Selected Transcatheter Techniques
			1.1.2.3.1 Percutaneous Transluminal Coronary Angioplasty
			1.1.2.3.2 Coronary Stenting
			1.1.2.3.3 Other Transcatheter Methods
				1.1.2.3.3.1 Vulnerable Plaque Identification

Exhibit 1-1: Prevalence Figures for Selected Forms of Cardiovascular Disease in the United States 
Exhibit 1-2: Ischemic Heart Disease Diagnoses for Patients Discharged from Acute Care Hospitals, 1995-1999 
Exhibit 1-3: Coronary Atherosclerosis Diagnoses in Discharged Hospital Patients, 1995-1999 
Exhibit 1-4: Standard Angina Pectoris Classification 
Exhibit 1-5: 2001, Low-Density Lipoprotein Cholesterol, Target and Drug Therapy Initiation Levels 
Exhibit 1-6: Coronary Artery Bypass Grafting, Inpatient Discharges, 1985-1999 
Exhibit 1-7: 2001, Selected Vulnerable Plaque Detection Technologies in Development 
 
2.   PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY PRODUCTS MARKET

2.1 Percutaneous Transluminal Coronary Angioplasty
	2.1.1 Approaches
	2.1.2 Applications
	2.1.3 Efficacy
		2.1.3.1 Complications
		2.1.3.2 Outcomes
	2.1.4 Anti-Clotting Drug Effects
	2.1.5 Restenosis
	2.1.6 Costs
	2.1.7 Procedure Volumes
2.2 Percutaneous Transluminal Coronary Angioplasty Products
	2.2.1 Balloon Catheters
		2.2.1.1 Market Forecast
		2.2.1.2 Competitive Analysis
	2.2.2 Guiding Catheters
		2.2.2.1 Market Forecast
		2.2.2.2 Competitive Analysis
	2.2.3 Guidewires
		2.2.3.1 Market Forecast
		2.2.3.2 Competitive Analysis
	2.2.4 Introducer Sheaths
		2.2.4.1 Market Forecast
		2.2.4.2 Competitive Analysis
	2.2.5 Inflation Devices
		2.2.5.1 Market Forecast
		2.2.5.2 Competitive Analysis
	2.2.6 Arterial Access Closure Devices
		2.2.6.1 Market Forecast
		2.2.6.2 Competitive Analysis
2.3 Technological Developments in Percutaneous Transluminal Coronary Angioplasty
	2.3.1 Embolic Protection Devices
		2.3.1.1 Distal Filter Devices
		2.3.1.2 Distal Balloon Occlusion Devices
		2.3.1.3 Proximal Balloon Occlusion Devices
		2.3.1.4 Market Analysis
	2.3.2 Other Areas of Technological Development

Exhibit 2-1:Complications Associated with the Performance of Percutaneous Transluminal Coronary Angioplasty 
Exhibit 2-2:Post-Percutaneous Transluminal Coronary Angioplasty Target Vessel Revascularization Rates 
Exhibit 2-3:Costs Associated with Percutaneous Transluminal Coronary Angioplasty 
Exhibit 2-4:2001, Estimated Consumables Cost per Percutaneous Transluminal Coronary Angioplasty Procedure 
Exhibit 2-5:Percutaneous Transluminal Coronary Angioplasty, Historic Procedure Volumes, 1985-1999 
Exhibit 2-6:Percutaneous Transluminal Coronary Angioplasty, Combined Inpatient and Outpatient Procedure Volumes, 1985-2001 
Exhibit 2-7:Types of Percutaneous Transluminal Coronary Angioplasty Balloon Catheters 
Exhibit 2-8:2001, Selected Percutaneous Transluminal Coronary Angioplasty Balloon Catheters 
Exhibit 2-9:Percutaneous Transluminal Coronary Angioplasty Balloon Catheters, Market Forecast, 2000-2006 
Exhibit 2-10: 2000, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters Market, Share by Supplier 
Exhibit 2-11: 2002, Selected Coronary Guiding Catheters 
Exhibit 2-12: Coronary Guiding Catheters, Market Forecast, 2000-2006 
Exhibit 2-13: 2000, Coronary Guiding Catheters Market, Share by Supplier 
Exhibit 2-14: 2002, Selected Coronary Guidewires 
Exhibit 2-15: Coronary Guidewires, Market Forecast, 2000-2006 
Exhibit 2-16: 2000, Coronary Guidewires Market, Share by Supplier 
Exhibit 2-17: 2001, Selected Introducer Sheaths 
Exhibit 2-18: Introducer Sheaths, Market Forecast, 2000-2006 
Exhibit 2-19: 2000, Introducer Sheaths Market, Share by Supplier 
Exhibit 2-20: 2002, Selected Percutaneous Transluminal Coronary Angioplasty/Stenting Inflation Devices 
Exhibit 2-21: Percutaneous Transluminal Coronary Angioplasty/Stenting Inflation Devices, Market Forecast, 2000-2006
Exhibit 2-22: 2000, Percutaneous Transluminal Coronary Angioplasty/ Stenting Inflation Devices Market, Share by Supplier 
Exhibit 2-23: 2002, Selected Arterial Access Closure Devices 
Exhibit 2-24: Arterial Access Closure Devices, Market Forecast, 2000-2006 
Exhibit 2-25: 2000, Arterial Access Closure Devices, Share by Supplier 
Exhibit 2-26: Comparison of Embolic Protection Device Designs 
 
3. CORONARY STENT PRODUCTS MARKET

3.1 Types of Coronary Stents
	3.1.1 Materials
		3.1.1.1 Stainless Steel
		3.1.1.2 Nitinol
		3.1.1.3 Tantalum
		3.1.1.4 Other Materials
	3.1.2 Coatings
		3.1.2.1 Coated Stents
		3.1.2.2 Drug-Eluting Stents
		3.1.2.3 Covered Stents
	3.1.3 Designs
		3.1.3.1 Mesh
		3.1.3.2 Coil
		3.1.3.3 Slotted-Tube
		3.1.3.4 Other Configurations
	3.1.4 Diameters
	3.1.5 Radiopacity
3.2 Coronary Stenting Applications and Approaches
	3.2.1 Stent Delivery
	3.2.2 Stent Deployment
	3.2.3 Efficacy
		3.2.3.1 Clinical Studies
		3.2.3.2 Outcomes
	3.2.4 Complications
	3.2.5 Restenosis
	3.2.6 Costs
	3.2.7 Procedure Volumes
3.3 Coronary Stent Products
	3.3.1 Pricing Trends
	3.3.2 Market Forecast
	3.3.3 Competitive Analysis
3.4 Coronary Stent Restenosis Treatment Systems
	3.4.1 Pricing Trends
	3.4.2 Market Forecast
	3.4.3 Competitive Analysis

Exhibit 3-1:Costs Associated with Coronary Stenting 
Exhibit 3-2:2001, Estimated Consumables Cost per Coronary Stenting Procedure 
Exhibit 3-3:Coronary Stent Implantations, Historic and Forecast Procedure Volumes, 1993-2006 
Exhibit 3-4:2002, Selected Coronary Stent Systems 
Exhibit 3-5:Coronary Stent Systems, Market Forecast, 2000-2006 
Exhibit 3-6:2000, Coronary Stent Systems Market, Share by Supplier 
Exhibit 3-7:2002, Selected Restenosis Treatment Products and Technologies 
Exhibit 3-8:Intravascular Brachytherapy Systems, Market Forecast, 2000-2006 
Exhibit 3-9:2001, Intravascular Brachytherapy Systems Market, Share by Supplier 
  
4.   GENERAL ISSUES IN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY AND CORONARY STENTING

4.1 Managed Care, Third-Party Payers, and Reimbursement
4.2 Regulatory Concerns
4.3 Group Purchasing Organizations

Exhibit 4-1:Projected Growth in Medicare/Medicaid Spending Versus Gross Domestic Product 
 
5. COMPANY PROFILES

5.1 Biocompatibles International PLC
5.2 Boston Scientific Corporation
5.3 Cook, Inc./Cook Group
5.4 Cordis Corporation/Johnson & Johnson
5.5 Guidant Corporation
5.6 JOMED NV
5.7 Kensey Nash Corporation
5.8 Perclose/Abbott Laboratories
5.9 PharmaSonics, Inc.
5.10 Medtronic, Inc.
5.11 Merit Medical Systems, Inc.
5.12 Microvena Corporation
5.13 Novoste Corporation
5.14 Radiance Medical Systems, Inc.
5.15 St. Jude Medical, Inc.
5.16 SurModics, Inc.
 
COMPANY LISTING


COMPANIES COVERED:

  1. Biocompatibles International PLC
  2. Boston Scientific Corporation
  3. Cook, Inc./Cook Group
  4. Cordis Corporation/Johnson & Johnson
  5. Guidant Corporation
  6. JOMED NV
  7. Kensey Nash Corporation
  8. Perclose/Abbott Laboratories
  9. PharmaSonics, Inc.
  10. Medtronic, Inc.
  11. Merit Medical Systems, Inc.
  12. Microvena Corporation
  13. Novoste Corporation
  14. Radiance Medical Systems, Inc.
  15. St. Jude Medical, Inc.
  16. SurModics, Inc.
Contact Us

Need help finding medtech research? Let us help you!